70 related articles for article (PubMed ID: 6298513)
1. [Importance of the administration of synacthen (beta 1-24 corticotropin) in the therapeutic protocol of patients with neoplasms in an advanced stage].
de Broucker D; Graux P
LARC Med; 1982 Oct; 2(9):806-8. PubMed ID: 6298513
[No Abstract] [Full Text] [Related]
2. Measurement of the adrenal cortex reserve using depot beta 1-24-corticotrophin. II---in thyroid diseases.
Galvão-Teles A
Acta Med Port; 1979; 1(3):315-24. PubMed ID: 233190
[No Abstract] [Full Text] [Related]
3. [7-Methyltryptophan9]-beta-corticotropin-(1-24): a hyperactive Synacthen analogue.
Allen MC; Bailey PD; Brundish DE; Jones JH; Wade R; Young GT
Int J Pept Protein Res; 1984 Nov; 24(5):529-31. PubMed ID: 6097558
[TBL] [Abstract][Full Text] [Related]
4. [Synthetic ACTH in theumatic diseases: (author's transl)].
Hieber F
MMW Munch Med Wochenschr; 1975 Nov; 117(46):1849-52. PubMed ID: 172785
[TBL] [Abstract][Full Text] [Related]
5. [Use of Cortrosyn Depot in dermatology].
Aussems J
Brux Med; 1976 Jan; 56(1):15-20. PubMed ID: 175889
[No Abstract] [Full Text] [Related]
6. [Studies on the antigenicity of synthetic ACTH (beta1-24-corticotropin) in normal subjects (author's transl)].
Mauff G; Weinheimer B; Urbaschek B
Arzneimittelforschung; 1975 Nov; 25(11):1823-6. PubMed ID: 173352
[TBL] [Abstract][Full Text] [Related]
7. [Tetracosactid (Synacthen) as a therapeutic alternative in uveitis and other chronic inflammations of the eye].
Fricke HJ; Heydenreich A; Thiel U; Schröder D
Klin Monbl Augenheilkd; 1983 Jul; 183(1):10-6. PubMed ID: 6310203
[No Abstract] [Full Text] [Related]
8. [Long-term Cortrosyn-depot therapy of steroid-dependent patients suffering from bronchial asthma].
Rott Z; Fajt E; Tóth S; Hammer I; Nagy G
Orv Hetil; 1983 Jul; 124(31):1883-6. PubMed ID: 6314223
[No Abstract] [Full Text] [Related]
9. [Synacthen therapy and prostatic carcinoma?].
Staehler W; Ziegler H
Med Welt; 1975 Apr; 26(14):682. PubMed ID: 169454
[No Abstract] [Full Text] [Related]
10. [Severe bronchial obstruction as a reaction to the administration of the tetracosactides depot-Cortrosyn and depot-Synacthen].
Roldaan AC; de Jong C
Ned Tijdschr Geneeskd; 1981 Feb; 125(8):321-3. PubMed ID: 6261167
[No Abstract] [Full Text] [Related]
11. Megestrol acetate therapy and secondary adrenal suppression.
Naing KK; Dewar JA; Leese GP
Cancer; 1999 Sep; 86(6):1044-9. PubMed ID: 10491532
[TBL] [Abstract][Full Text] [Related]
12. Short course of synacthen therapy as an adjunct in the management of rheumatoid arthritis.
Ben-Chetrit E; Naparstek Y; Ehrenfeld M; Eliakim M
Clin Rheumatol; 1985 Jun; 4(2):155-60. PubMed ID: 2988847
[TBL] [Abstract][Full Text] [Related]
13. Corticotrophin and tetracosactrin depot-self-administered for the treatment of eczema.
Munro DD
Br J Dermatol; 1976 Mar; 94 suppl 12():135-8. PubMed ID: 178340
[TBL] [Abstract][Full Text] [Related]
14. [Synacthen retard].
Ménégol B; Brard M
Soins; 1985 Apr; (451):I-II. PubMed ID: 3008345
[No Abstract] [Full Text] [Related]
15. [The use of synthetic beta-1-24 corticotropin as a GH stimulating factor (author's transl)].
La Cauza C; Nicótina PA; Seminara S
Ann Endocrinol (Paris); 1976; 37(1):33-40. PubMed ID: 189671
[TBL] [Abstract][Full Text] [Related]
16. Dose-response relation between plasma concentrations of corticotropin and cortisol after administration of incremental doses of cosyntropin for corticotropin stimulation testing in cats.
Peterson ME; Kemppainen RJ
Am J Vet Res; 1993 Feb; 54(2):300-4. PubMed ID: 8381628
[TBL] [Abstract][Full Text] [Related]
17. Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followup.
Taylor WJ; Rajapakse CN; Harris KA; Harrison AA; Corkill MM
J Rheumatol; 1999 Dec; 26(12):2544-50. PubMed ID: 10606361
[TBL] [Abstract][Full Text] [Related]
18. Diverticular disease treated with corticotrophin.
Steer C
J R Coll Gen Pract; 1985 Nov; 35(280):532-3. PubMed ID: 3001302
[TBL] [Abstract][Full Text] [Related]
19. [Fatal complication of intravenous administration of synthetic adrenocorticotrophin].
Müller M; Fehm HL; Homoki J; Teller WM
Dtsch Med Wochenschr; 1982 Sep; 107(36):1353-6. PubMed ID: 6288339
[TBL] [Abstract][Full Text] [Related]
20. [Gonado-adrenal interaction in cryptorchidism. Response of plasma androgens to stimulation with beta-1,24-corticotropin].
Altomonte G; Agostino A; Jacobelli A
Minerva Endocrinol; 1984; 9(3):343-7. PubMed ID: 6152480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
